In response to rapid developments in psychopharmacology, this is a spin-off from Stephen M. Stahlís new, completely revised and updated version of his much-acclaimed Prescriberís Guide. It covers the most important drugs in use today for treating depression. In full color throughout, and with four or more pages for each antidepressant, Stephen M. Stahl distills his great expertise into a pragmatic formulary that gives all the information a prescriber needs to treat patients effectively. Each drug is covered in five categories: general therapeutics, dosing and use, side effects, special populations, and pearls. Target icons appear next to key categories for each drug so that the prescriber can go easily and instantly to the information needed. Several indices are included, listing drugs by name (generic and international) and use. In addition, Dr. Stahl indicates which drugs have FDA approval and also gives the FDA Use-in-Pregnancy Ratings.
1. Amitriptyline; 2.Amoxapine; 3. Aripiprazole; 4. Atomoxetine; 5. Bupropion; 6. Citalopram; 7. Clomipramine; 8. Desipramine; 9. Desvenlafaxine; 10. Dothiepin; 11. Doxepin; 12. Duloxetine; 13. Escitalopram; 14. Fluoxetine; 15. Fluvoxamine; 16. Imipramine; 17. Isocarboxazid; 18. Lofepramine; 19. Maprotiline; 20. Milnacipran; 21. Mirtazapine; 22. Moclobmide; 23. Nefazodone; 24. Notriptyline; 25. Paroxetine; 26. Phenelzine; 27. Protriptyline; 28. Quetiapine; 29. Reboxetine; 30. Selegiline; 31. Sertraline; 32. Tianeptine; 33. Tranylcypromide; 34. Trazodone; 35. Trimipramine; 36. Venlafaxine.
About the Author:
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California at San Diego School of Medicine. He has conducted numerous research projects awarded by the National Institute of Mental Health, the Veterans Administration, and the pharmaceutical industry. The author of more than 300 articles and chapters, Stephen M. Stahl is an internationally recognized clinician, researcher, and teacher in psychiatry with subspecialty expertise in psychopharmacology.